Publication

Peer-Reviewed

Evidence-Based Oncology

February 2021
Volume27
Issue 2

Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Related Videos
Screenshot of Adam Colborn, JD during an interview
Screenshot of an interview with Stuart Staggs
Stuart Staggs
Lalan Wilfong, MD, during a video interview
dr katherine baker
Dr Julie Patterson, National Pharmaceutical Council
Ben Jones, McKesson/Us Oncology
Kathy Oubre, MS, Pontchartrain Cancer Center
Julie Patterson, PharmD, PhD, National Pharmaceutical Council
Leslie Busby, MD, Rocky Mountain Cancer Centers
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo